Mercy BioAnalytics
  • Home
  • The Mercy Halo Test
  • News
  • Publications
    • Support for Mercy Halo
    • Support for Extracellular Vesicles
  • About Mercy
    • Team Mercy
    • Advisors
    • The Mercy Way
    • Mercy Foundation
  • Contact
    • Careers
Select Page

Novel Assay for Early Detection of Ovarian Cancer from Mercy BioAnalytics Significantly Outperforms CA125 in New Research Presented at ASCO Annual Meeting

by mercyevadmin | May 27, 2022 | News

Mercy Halo Data Demonstrates Promise of Novel Extracellular Vesicle Biomarker-Based Approach for Early Cancer Detection Natick, MA – May 27, 2022 – Mercy BioAnalytics™, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of...

Recent News

  • Novel Assay for Early Detection of Ovarian Cancer from Mercy BioAnalytics Significantly Outperforms CA125 in New Research Presented at ASCO Annual Meeting
Copyright © 2022. Mercy BioAnalytics™. All rights reserved.